UHS Reports Q3 2026 Net Income of $308.7M, Announces Tentative Settlement in Cumberland Litigation

Universal Health Services, Inc. (NYSE: UHS) reported financial results for the three and nine-month periods ended September 30, 2026, in a filing dated October 27, 2026.

For the third quarter of 2026, reported net income attributable to UHS was $308.7 million, or $5.22 per diluted share. This represents a decrease from the $373.0 million, or $5.86 per diluted share, reported in the same period of 2025. Net revenues for the third quarter of 2026 increased by 5.3% to $4.733 billion, compared to $4.495 billion in the prior year.

For the first nine months of 2026, reported net income attributable to UHS was $1.016 billion, or $16.86 per diluted share. This is a slight decrease from the $1.043 billion, or $16.07 per diluted share, reported during the comparable period of 2025. Net revenues for the nine-month period increased by 7.7% to $13.867 billion.

On an adjusted basis, which excludes certain non-operating items, net income for the third quarter of 2026 was $308.7 million, or $5.22 per diluted share. For the first nine months of 2026, adjusted net income was $1.014 billion, or $16.83 per diluted share.

Regarding operating metrics, on a same facility basis, adjusted admissions and adjusted patient days at acute care hospitals increased by 4.9% during the third quarter of 2026 compared to 2025. Net revenues from acute care services on a same facility basis increased by 4.7% for the quarter. For behavioral health care services, net revenues on a same facility basis increased by 4.0% during the third quarter of 2026.

In terms of capital resources, the company reported net cash provided by operating activities of $1.481 billion for the nine-month period ended September 30, 2026, an increase of 14.9% from the prior year. As of September 30, 2026, the company had $1.187 billion of available borrowing capacity under its $1.5 billion revolving credit facility.

UHS also announced a tentative settlement agreement to resolve all outstanding claims related to the Cumberland Litigation, a matter involving its subsidiary Cumberland Hospital for Children and Adolescents. The settlement is subject to final release agreements and court approvals. The company stated that a substantial portion of the settlement is covered by commercial excess insurance, with the remainder covered by reserves.